Skip to content

Yoga Intervention for Substance Use and ART Adherence in Community Reentry

Yoga Intervention for Substance Use and Antiretroviral Therapy Adherence in Community

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02492893
Enrollment
72
Registered
2015-07-09
Start date
2014-12-31
Completion date
2016-02-29
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV, Substance Related Disorders

Brief summary

People with HIV and a substance use disorder who are reentering the community from prison or jail face the dual risks of relapse and interruptions in adherence to antiretroviral therapy (ART) medication. This mixed-methods randomized controlled trial will compare the stress, substance use and ART adherence outcomes of participants in a 12-session, 90-minute weekly yoga group intervention with participants in a treatment as usual control group. All participants are re-entering the community, have HIV and experience substance use challenges.

Interventions

OTHERHatha yoga

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Peter McManus Charitable Trust
CollaboratorOTHER
National Coalition of Independent Scholars
CollaboratorUNKNOWN
University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* have HIV * experience substance use challenges, within one year of reentry from prison or jail

Design outcomes

Primary

MeasureTime frame
Stress: Perceived Stress Scale (self-report)3 months
Substance use: Time Line Follow Back (self-report)3 months

Secondary

MeasureTime frame
Heart rate: sphygmomanometer3 months
Blood pressure: sphygmomanometer3 months
Viral load: blood test3 months
Antiretroviral therapy adherence: prescription refill (pharmacy data)3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026